For this, the CM of Lewis lung carcinoma and fibrosarcoma tumor cell lines (3LL and MN/MCA, respectively) were added to hematopoietic bone marrow progenitor cultures on day 1 along with M-CSF treatment, and replaced on day 4. Here, CSF1 is linked to neoplasm.